S&P 500 Industrials Sector SEC Filings — June 01, 2026

01-06-2026

Dala Group, LLC filed its 13F-HR for the quarter ended March 31, 2026, reporting a total portfolio value of approximately $119.6 million across 73 equity holdings. The portfolio is heavily weighted toward ETFs, with top positions in the Invesco S&P MidCap Momentum ETF ($15.1M), DBX Xtrack MSCI EAFE ETF ($12.2M), and Vanguard Dividend Appreciation ETF ($11.8M). The filing shows a diversified strategy with significant exposure to U.S. large-cap, mid-cap, and international equities, but no prior-quarter comparison is available to assess performance trends.

• · The portfolio's largest single stock holding by value is Alphabet Inc Class A at $11.7 million (40,744 shares).
• · The top ETF holdings include Invesco S&P MidCap Momentum ETF ($15.1M), DBX Xtrack MSCI EAFE ETF ($12.2M), and Vanguard Dividend Appreciation ETF ($11.8M).
• · The portfolio has significant exposure to technology and growth stocks, including Apple ($2.7M), Microsoft ($1.8M), Amazon ($1.8M), and NVIDIA ($1.5M).
• · International exposure is provided through ETFs such as DBX Xtrack MSCI EAFE ($12.2M), WisdomTree Japan Hedged Equity ($2.1M), and Dimensional Emerging Markets ($1.1M).
• · The filing indicates all holdings are held with sole voting and dispositive power, with no shared or other authority reported.

01-06-2026

AITX announced that its subsidiary RAD scaled production, with Q1 FY27 hardware device shipments exceeding 100 units. The company issued a press release on June 1, 2026, highlighting this milestone. No financial figures or period-over-period comparisons were provided in the filing.

• · The press release is titled 'AITX’s RAD Scales Production as Q1 FY27 Shipments Exceed 100 Hardware Devices'.
• · The filing is an 8-K under Items 8.01 and 9.01, and the press release is attached as Exhibit 99.1.
• · The company's principal executive offices are located at 10800 Galaxie Avenue, Ferndale, MI 48220.

01-06-2026

Public Storage released an investor presentation with an operating update for April 1 through May 28, 2026. Same-store occupancy remained stable at 92.2% (up 0.1% YoY) and churn improved to 16.4% from 19.6% (down 3.2%). However, average annual contract rent for customers moving in declined 0.2% to $13.10/sq ft, and for customers moving out it fell 4.1% to $18.98/sq ft, indicating pricing pressure.

• · Same-store facilities consist of 2,755 facilities (192.1 million net rentable square feet) owned and operated on a stabilized basis since January 1, 2024.
• · The investor presentation was posted on the Investor Relations section of the company's website on June 1, 2026.

01-06-2026

On May 27, 2026, Thomas Earl, Chief Commercial Officer of VG LNG Marketing, LLC (UK Branch), an indirect wholly-owned subsidiary of Venture Global, Inc., notified the company he will step down from his executive role effective June 1, 2026. He will remain an employee in a non-executive capacity for one year. Internal personnel have been identified to assume his duties.

• · Thomas Earl's resignation is effective June 1, 2026.
• · He will remain an employee in a non-executive capacity for a term of one year.
• · Internal personnel have been identified to assume his previous duties and responsibilities.
• · The filing was signed by Jonathan Thayer, Chief Financial Officer, on May 29, 2026.

01-06-2026

Flutter Entertainment plc filed an 8-K with amendments to its Memorandum and Articles of Association, reflecting changes adopted through resolutions up to and including May 29, 2026. The filing confirms the company's authorized share capital remains €27,000,000 divided into 300,000,000 ordinary shares of €0.09 each, with no material changes to business objects or corporate governance structure disclosed.

• · The company was originally incorporated on April 2, 1958.
• · The Memorandum of Association includes 38 enumerated business objects, covering betting/gaming, holding company activities, investments, and financial instruments.
• · Articles of Association were amended to incorporate resolutions passed up to May 29, 2026, but no specific amendments are detailed in this excerpt.
• · The filing asserts that only Sections 83 and 84 of the Companies Act 2014 apply as optional provisions; all other optional provisions are excluded.

01-06-2026

FedEx Freight Holding Company, Inc. completed its spin-off from FedEx Corporation on June 1, 2026, and began trading on the NYSE under ticker FDXF. The spin-off was effected through a pro rata distribution of 80.1% of FedEx Freight shares to FedEx stockholders (one FDXF share for every two FDX shares), while FedEx retained 19.9% of shares to be disposed of within 24 months. The company positions itself as the largest pure-play LTL carrier in North America with over 26,000 service center doors, nearly 30,000 vehicles, and 40,000 team members, and expects to join the S&P 500 and Dow Jones Transportation Average. No financial performance data or period-over-period comparisons were provided in this filing.

• · FedEx Freight will join the S&P 500 and Dow Jones Transportation Average.
• · FedEx retained 19.9% of FedEx Freight shares, to be disposed of within 24 months via exchanges for debt repayment or distributions to stockholders.
• · FedEx Freight operates across all 50 U.S. states, Canada, Mexico, Puerto Rico, and the U.S. Virgin Islands.
• · The spin-off distribution ratio was one FDXF share for every two FDX shares held as of May 15, 2026.
• · Financial advisors: Goldman Sachs & Co. LLC and J.P. Morgan Securities LLC; legal counsel: Skadden, Arps, Slate, Meagher & Flom LLP.

01-06-2026

FedEx Corp. completed the spin-off of FedEx Freight, creating two independent public companies. FedEx Freight begins trading on NYSE under ticker FDXF. FedEx distributed 80.1% of FedEx Freight shares to stockholders on a pro rata basis (1 share per 2 FDX shares) and retained 19.9%, which it plans to dispose of within 24 months. The spin-off is intended to position both companies for long-term value creation, but forward-looking statements highlight risks including potential disruption and unanticipated costs.

• · Spin-off effective date: June 1, 2026.
• · Record date for distribution: May 15, 2026.
• · FedEx will dispose of retained 19.9% stake within 24 months via exchanges for debt repayment or distributions to stockholders.
• · FedEx aims for carbon-neutral operations by 2040.
• · Forward-looking statements caution about risks including disruption, litigation, and unanticipated costs.

01-06-2026

Diana Shipping Inc. filed an amended Schedule 13D/A disclosing its tender offer to acquire all outstanding shares of Genco Shipping & Trading Ltd at $24.80 per share, now beneficially owning 6,264,548 shares (14.4% of class). The filing includes an open letter and video message urging Genco shareholders to elect Diana’s six independent director nominees at the June 18, 2026 annual meeting, while criticizing the Genco board for spending over $13 million on defensive advisors and failing to engage on the offer. However, the tender offer has not yet been accepted by the board, and Diana notes that Genco’s share price could revert to ~$18.00 (a ~30% discount to NAV) if no deal is completed.

• · Diana's offer represents ~1.0x NAV at cyclically high asset values, while comparable industry buyouts trade at ~0.80x NAV.
• · Genco had 43,577,051 common shares outstanding as of May 6, 2026.
• · The tender offer expires at 5:00 p.m. New York City time on June 26, 2026.
• · Genco's annual meeting is scheduled for June 18, 2026.
• · Diana has increased its offer three times (third proposal at $24.80).
• · John Wobensmith serves as both Chairman and CEO after adding the Chairman role in August 2025 as Diana was acquiring Genco shares.
• · A majority of Wobensmith's Genco stock was pledged as collateral for personal loans (since repaid).
• · Kathleen Haines was named co-defendant in three shareholder class action lawsuits alleging lack of independence while serving on the OSG America board.

01-06-2026

Science Applications International Corp (SAIC) announced the departure of Srinivas Attili, Executive Vice President, Civilian Business Group, effective May 29, 2026, with his final departure on or about June 12, 2026. The departure is in connection with an internal reorganization. Mr. Attili will receive severance compensation under the company's Executive Severance, Change in Control and Retirement Policy, subject to a release of claims and a two-year non-compete agreement. No financial figures or period-over-period comparisons are provided in this filing.

• · Mr. Attili stepped down from his role on May 29, 2026, and will depart the company on or about June 12, 2026.
• · Severance compensation is pursuant to Section 5 of the company's Executive Severance, Change in Control and Retirement Policy.
• · The severance requires execution and non-revocation of a release of claims and a two-year post-employment non-compete obligation.

01-06-2026

Global Net Lease, Inc. (GNL-PD) filed an S-4 registration statement on June 1, 2026, regarding its merger with Modiv Inc. Under the Merger Agreement, each share of Modiv common stock will be converted into 1.975 newly issued shares of GNL common stock, with a fixed exchange ratio not subject to market price adjustments. Closing conditions include Modiv stockholder approval, absence of legal prohibitions, and delivery of certain tax opinions; the deal is not subject to a financing condition or GNL stockholder approval. However, the merger faces risks including potential failure to close by the February 3, 2027 deadline, dilution — with legacy GNL stockholders expected to own about 89% and Modiv stockholders about 11% of the combined company — and the possibility of a $10 million to $15 million termination fee payable by Modiv under certain circumstances.

• · The exchange ratio of 1.975 GNL shares per Modiv share is fixed and will not be adjusted for changes in stock prices, though adjustments are possible for stock splits, dividends, or recapitalizations.
• · Based on GNL stock prices from May 1-29, 2026, the exchange ratio implied a per-share market value for Modiv ranging from $17.83 to $18.82.
• · Modiv stockholders will vote on the merger; GNL stockholder approval is not required.
• · Neither GNL nor Modiv can assure that all conditions will be satisfied or waived by the February 3, 2027 outside date.
• · The merger will divert management attention and may adversely affect operations, financial condition, and ability to make distributions.
• · Modiv is restricted from soliciting alternative transactions and must pay termination fees if it changes its recommendation or breaches covenants.
• · Modiv Board received a fairness opinion from Truist dated May 3, 2026, but the opinion does not reflect subsequent developments.

01-06-2026

SPACSphere Acquisition Corp. (SSAC) announced a business combination with Mobilewalla, valuing the latter at a pro forma enterprise value of $250 million. The transaction is expected to close with Mobilewalla becoming a publicly traded company on Nasdaq under a new ticker symbol. However, the filing contains no financial performance data for either company, and the forward-looking statements highlight significant risks, including the possibility that the deal may not be completed in a timely manner or at all.

• · The filing is a letter to shareholders from Mobilewalla, not from SSAC.
• · The transaction is subject to shareholder approvals from both SSAC and Mobilewalla, as well as regulatory approvals.
• · SSAC's business combination deadline is a risk factor; failure to complete by the deadline could require an extension.
• · SSAC's securities are listed on Nasdaq under the ticker SSAC, with Commission File No. 001-43093.
• · The joint press release is available at https://www.mobilewalla.com/about/press/mobilewalla-enters-into-business-continuity-agreement-with-spacsphere.
• · The registration statement on Form S-4 will contain the proxy statement/prospectus for the transaction.
• · SSAC's prospectus for its IPO (File No. 333-290414) was declared effective on January 30, 2026.
• · SSAC's most recent Annual Report on Form 10-K was filed on March 27, 2026.

01-06-2026

Eloxx Pharmaceuticals, Inc. filed a Certificate of Amendment to effect a 1-for-11 reverse stock split of its Common Stock, effective as of 5:00 p.m. Eastern time on the filing date (June 1, 2026). The amendment, approved by stockholders and the Board, reduces the authorized Common Stock from an unspecified prior amount to 100,000,000 shares (par value $0.01) and authorized Preferred Stock remains at 5,000,000 shares. No fractional shares will be issued; holders otherwise entitled to a fractional share will receive a cash payment based on fair market value.

• · The reverse stock split was approved by written consent of stockholders.
• · The amendment was adopted under Section 242 of the Delaware General Corporation Law.
• · The par value of Common Stock remains $0.01 per share after the reverse split.
• · The Board of Directors retains authority to issue Preferred Stock in series with varying rights, including redemption, dividends, and conversion.

01-06-2026

Weatherford International plc announced a definitive agreement to acquire NCS Multistage Holdings, Inc., expected to close in H2 2026. The acquisition aims to expand Weatherford's well completions and unconventional reservoir capabilities. No financial terms were disclosed.

• · Transaction expected to close in second half of 2026, subject to regulatory approvals.
• · Pre-integration team established under Manoj Nimbalkar.
• · Employees instructed not to alter pricing or engage customers on combined capabilities until close.
• · Weatherford and NCS Multistage will operate independently until close.

01-06-2026

Elite Pharmaceuticals filed an Abbreviated New Drug Application (ANDA) with the FDA for a generic version of an undisclosed anticoagulant drug. The filing was disclosed via press release on June 1, 2026, and furnished as an exhibit to this Form 8-K. This is a positive step toward potential market entry, though no financial terms or approval timelines were provided.

• · The drug product is in the class of anticoagulants, but the specific drug was not disclosed.
• · Common stock trades on OTCQB under symbol ELTP.
• · The press release is dated June 1, 2026, while the report is signed on the same date.

01-06-2026

Cabaletta Bio, Inc. filed a DEFA14A supplement to its 2026 proxy statement, announcing the withdrawal of Proposal 3 (amendment to the 2019 Stock Option and Incentive Plan) from the June 9, 2026 annual meeting agenda. The Board decided on May 31, 2026, after further discussions with management and advisors, to remove the proposal. All other proposals (1, 2, 4, 5, and 6) remain on the agenda, and previously submitted proxy cards remain valid for those items. The company intends to continue evaluating its equity compensation program and may propose a similar amendment in the future.

• · The record date for the annual meeting remains April 20, 2026.
• · The annual meeting is scheduled for June 9, 2026, at 9:00 a.m. Eastern Time, accessible via live webcast at www.proxydocs.com/CABA.
• · No new proxy cards or voting instructions are needed solely due to the removal of Proposal 3.
• · Proxy cards with direction on Proposal 3 will not be voted on that proposal.
• · Previously submitted proxy cards for Proposals 1, 2, 4, 5, and 6 remain valid and will be voted as directed.

01-06-2026

Garrett Motion Inc. held its 2026 Annual Meeting on May 28, 2026, where all eight director nominees were elected, and both the ratification of Deloitte SA as independent auditor for 2026 and the advisory vote on executive compensation were approved. While support for directors and proposals was generally strong, a notable 13,881,118 broker non-votes were recorded for Items 1 and 3, and Item 2 had 1,224,803 votes against ratification, indicating modest shareholder dissent.

• · Item 1 director voting: Daniel Ninivaggi received 148,585,656 votes FOR, Paul Camuti 145,476,602, Joachim Drees 151,035,367, D'aun Norman 149,127,531, Olivier Rabiller 151,052,826, Julia Steyn 151,130,438, Steven Tesoriere 150,931,270, Jeffrey Vanneste 151,343,062.
• · Broker non-votes for Items 1 and 3 totaled 13,881,118 each.
• · Item 2 (ratification of Deloitte SA): 164,399,648 FOR, 1,224,803 AGAINST, 35,548 ABSTAINED.
• · Item 3 (advisory vote on executive compensation): 147,402,471 FOR, 4,099,169 AGAINST, 277,241 ABSTAINED.
• · Meeting date: May 28, 2026; Proxy Statement filed April 10, 2026.

01-06-2026

Dmitri Stockton notified Deere & Company's Board on May 26, 2026, that he will not stand for re-election as a director at the 2027 annual meeting. He will serve the remainder of his current term, which expires at the 2027 meeting, and his decision is not due to any disagreement with the company. The Board thanked him for nearly 12 years of service.

• · Mr. Stockton's decision is not the result of any disagreement with the company, its operations, policies, or practices.
• · The Board looks forward to his continued service through the 2027 annual meeting.

01-06-2026

TDS subsidiary Array Digital Infrastructure (formerly U.S. Cellular) completed the sale of select spectrum assets to Verizon for $1.0 billion in cash on June 1, 2026. Concurrently, Array's Board declared a special cash dividend of $11.00 per share, with TDS holding a combined 70,788,703 shares of Array common and Series A common stock, resulting in a significant cash inflow to TDS.

• · The sale was completed under a License Purchase Agreement dated October 17, 2024.
• · The special dividend record date is June 11, 2026, and the payment date is June 25, 2026.
• · TDS held 33,005,877 shares of Series A Common Stock and 37,782,826 shares of Common Stock of Array as of June 1, 2026.

01-06-2026

01-06-2026

Hanover Bancorp, Inc. held its annual shareholder meeting on May 28, 2026, where shareholders elected three directors for three-year terms (Michael Katz, John R. Sorrenti, and Philip Okun) and approved the 2026 Equity Incentive Plan. The appointment of Crowe LLP as the independent auditor for fiscal year 2026 was also ratified. All proposals passed with strong shareholder support, though there were 903,723 broker non-votes on the director election and equity plan proposals.

• · The 2026 Equity Incentive Plan was approved with 4,755,228 FOR votes, 27,522 AGAINST, and 43,684 ABSTAIN.
• · Ratification of Crowe LLP as independent auditor received 5,725,927 FOR, 2,908 AGAINST, and 1,322 ABSTAIN, with no broker non-votes.
• · There were 903,723 broker non-votes on both the director election and the equity plan proposal.

01-06-2026

NSTS Bancorp, Inc. held its 2026 Annual Meeting on May 27, 2026, with 4,001,612 shares (76.05% of outstanding) represented. All three director nominees (Apolonio Arenas, Thomas J. Kneesel, and Rodney J. True) were elected, and the appointment of Plante & Moran, PLLC as independent auditor for fiscal 2026 was ratified with overwhelming support (3,708,805 votes for). However, each director nominee received over 1.2 million broker non-votes, indicating a significant portion of shares did not vote on the election.

• · The meeting was held on May 27, 2026, and the 8-K was filed on June 1, 2026.
• · Three director nominees were elected for three-year terms expiring at the 2029 Annual Meeting.
• · Thomas J. Kneesel received the highest number of votes for (2,575,890) among director nominees.
• · Rodney J. True received the highest number of votes withheld (300,988) among director nominees.
• · Broker non-votes were 1,207,967 for each director nominee, representing about 30.2% of shares present.
• · Ratification of Plante & Moran, PLLC received 3,708,805 votes for, 207,145 against, and 85,662 abstentions, with zero broker non-votes.

01-06-2026

BetterLife Pharma Inc. reported no revenue for the fiscal year ended January 31, 2026, with a net loss of $1,512,918, a significant improvement from the prior year's net loss of $3,621,884. Operating expenses decreased sharply to $1,607,739 from $5,000,113, driven by reductions in consulting fees, wages, and R&D spending. However, the company continues to face a working capital deficiency of $6,459,206 and minimal cash of $12,570, highlighting ongoing liquidity challenges.

• · Revenue remained nil for all three fiscal years presented (2026, 2025, 2024).
• · Research and development expenses fell to $85,672 in FY 2026 from $424,337 in FY 2025, an 80% decrease.
• · Consulting fees dropped to $169,982 from $1,122,455, an 85% decrease.
• · Wages, salaries and employment expenses decreased to $1,083,580 from $2,418,332, a 55% decrease.
• · The company recorded a gain on forgiveness/extinguishment of debts of $149,993 in FY 2026.
• · Net cash provided by financing activities was $629,263 in FY 2026, down from $1,992,540 in FY 2025.
• · Total assets declined slightly to $219,903 from $224,965 year-over-year.
• · The company had no investing activities in any of the three fiscal years.

01-06-2026

Barings BDC, Inc. (BBDC) entered into a Termination and Cancellation Agreement with Barings LLC on May 29, 2026, terminating the existing credit support agreement (CSA) originally established in connection with BBDC's acquisition of Sierra Income Corporation. Under the agreement, Barings LLC will make a cash payment of $67,027,611 to BBDC by June 30, 2026, settling obligations on certain investments, while a new CSA for $10,994,928 will be entered into for remaining investments. The settlement covers investments that have been realized, have a fair value of $500,000 or less, or are in an unrealized loss position as of the agreement date.

• · The original CSA was dated February 25, 2022, and provided up to $100 million in credit support for losses on investments acquired from Sierra in connection with the Merger Transaction.
• · The Cash Payment of $67,027,611 is due on or before June 30, 2026.
• · The Settled Obligation covers investments that have been realized, have a fair value of $500,000 or less, or are in an unrealized loss position as of the agreement date.
• · For investments with fair value of $500,000 or less, the settlement amount was calculated as if those investments had zero value.
• · The Cash Payment will be treated as gain attributable to termination of a right with respect to a capital asset for tax purposes under Section 1234A of the Internal Revenue Code.
• · The agreement is governed by New York law.

01-06-2026

On May 28, 2026, CitroTech Inc. entered into Exchange Agreements with holders of its Series A Preferred Stock, reacquiring all 1,666,667 outstanding shares of Series A Preferred Stock. In exchange, the company issued 103,558 shares of Series C Convertible Preferred Stock to BoltRock Holdings, LLC at closing and agreed to issue 467,012 shares of Series C Preferred Stock to TC Special Investments LLC after 18 months (or earlier upon a change of control, including the appointment of Theodore S. Ralston to the board). The transaction eliminates the Series A Preferred Stock entirely, but the deferred issuance to TCSI introduces future dilution risk.

• · The Exchange Agreements provide board designation or observer rights to holders while they maintain a 10% stake.
• · BoltRock Holdings receives certain limited consent rights for a period after closing.
• · The Series C Preferred Stock issued carries registration rights.
• · The company relied on Section 4(a)(2) of the Securities Act for exemption from registration.
• · Theodore S. Ralston's appointment to the board would trigger an earlier issuance of the TCSI shares under a change of control provision.

01-06-2026

West Pharmaceutical Services announced the appointment of Michel Lagarde as President and CEO effective August 31, 2026, succeeding Eric M. Green who will retire. The Board also elected Lead Independent Director Robert F. Friel as Board Chair. Lagarde brings extensive experience from Thermo Fisher Scientific and Patheon, and the company reported FY2025 net sales of $3.07 billion.

• · Michel Lagarde previously served as EVP and COO at Thermo Fisher Scientific, joining through the acquisition of Patheon N.V.
• · Lagarde holds a BBA from European University in Antwerp and an executive master's in finance and control from Maastricht University.
• · West has over 10,000 team members across 50 sites, including 26 manufacturing facilities worldwide.
• · The company delivers over 41 billion components and devices each year.
• · West is included on the S&P 500 index.

01-06-2026

Citius Pharmaceuticals, Inc. (CTXR) announced via its subsidiary Citius Oncology that Phase 1 clinical data for LYMPHIR (denileukin diftitox-cxdl) in combination with pembrolizumab in recurrent or refractory gynecologic malignancies were presented at the ASCO Annual Meeting. The study showed a 24% overall response rate (ORR) among 21 efficacy-evaluable patients and a 33% ORR in endometrial cancer patients previously treated with checkpoint inhibitors, with a median progression-free survival (mPFS) of 20.5 months among the 48% achieving clinical benefit. However, the overall mPFS across all evaluable patients was only 5.8 months, and 16 serious adverse events were observed at the highest dose level, highlighting the mixed nature of the early-stage data.

• · Median duration of response (mDOR) not yet reached; only 1 of 5 partial responders had progressed at analysis.
• · Current duration of response times: 4.2–35 months, median 21.1 months.
• · Overall mPFS across all 21 evaluable patients was 5.8 months (95% CI: 2.2 – NA).
• · Maximum tolerated dose was not achieved; only 1 case of reversible Grade 3 capillary leak syndrome at highest dose level.
• · No new safety signals or Grade 3+ immune-related adverse events observed.
• · LYMPHIR is not FDA-approved for gynecologic malignancies or any solid tumor; this was an investigational use.
• · Citius Oncology provided study drug and financial support; study designed and analyzed by UPMC investigators.
• · LYMPHIR was launched in the U.S. in December 2025 for relapsed/refractory Stage I–III CTCL.

01-06-2026

Black Rock Coffee Bar, Inc. held its Annual Meeting on May 27, 2026, where shareholders elected Jeff Hernandez and Kristina Cashman as Class I directors and ratified the appointment of Deloitte & Touche LLP as the independent auditor for fiscal year 2026, with strong support for both proposals.

• · Record date for the meeting was April 1, 2026.
• · Jeff Hernandez received 174,313,447 votes FOR, 7,442,148 WITHHELD; Kristina Cashman received 179,797,872 FOR, 1,957,723 WITHHELD.
• · Ratification of Deloitte & Touche LLP received 183,116,567 FOR, 2,247 AGAINST, 3,660 ABSTAINED, no broker non-votes.

01-06-2026

GEE Group Inc. (NYSE American: JOB) announced the resignation of Director Darla Moore, effective June 1, 2026, due to time commitments from her existing and new business endeavors. Ms. Moore had served on the Board since 2018 and chaired the Governance and Nominating Committees, also serving on the Audit, M&A, and Compensation Committees. The resignation was not due to any disagreement with the Company. No financial impact or performance metrics were disclosed in this filing.

• · Darla Moore had been a Board member since 2018, serving for 8 years.
• · She chaired the Governance and Nominating Committees and was a member of the Audit, M&A, and Compensation Committees.
• · The Company reiterated forward-looking statements and risk factors, including potential impacts from pandemics, economic conditions, and competition.

01-06-2026

Genesco Inc. filed an amendment (10-K/A) to its annual report for the fiscal year ended January 31, 2026, updating exhibits and financial data. The filing includes a PSU performance table showing actual adjusted operating income of $57,093,000 for fiscal 2024-2026, which is below the threshold of $267,435,000, resulting in a 0% payout rate. The amendment also incorporates various agreements and certifications.

• · The filing includes a Consulting Agreement with Cassandra E. Harris dated January 29, 2026.
• · The amendment updates exhibits related to credit agreements, trademark licenses, and insider trading policy.
• · Consents of Deloitte & Touche LLP and Ernst & Young LLP are included as exhibits.

01-06-2026

BlackRock ESG Capital Allocation Term Trust (ECAT) announced that all three leading proxy advisory firms—ISS, Egan-Jones, and Glass Lewis—recommend shareholders vote for the incumbent Board nominees on the WHITE card ahead of the June 9, 2026 annual meeting. The recommendations highlight the Board's successful shareholder-value initiatives, including a cumulative total shareholder return of +92.7% since January 2023 (vs. peer median of +58.8%), a 233% increase in the distribution rate, and over $100 million in share repurchases. However, ISS recommended voting for only seven of nine nominees, not the full slate, and the dissident's full slate was rejected by all three firms.

• · ISS recommended voting for seven of nine incumbent Board nominees, not the full slate.
• · Egan-Jones and Glass Lewis recommended voting for all nine incumbent Board nominees.
• · All three proxy advisors rejected the dissident's full slate of nominees.
• · The Fund has averaged the lowest discount to net asset value among competitor funds (1-year average discount as of April 30, 2026).
• · ECAT's term structure, managed distribution plan, and ESG mandate could be jeopardized if Saba gains control, according to Egan-Jones.
• · The annual meeting is scheduled for June 9, 2026.
• · Shareholders are advised to vote only on the WHITE proxy card and not to return any other proxy card.

01-06-2026

Embassy Bancorp, Inc. announced on June 1, 2026 that its Board of Directors approved an amendment to its existing common stock repurchase program, authorizing the purchase of an additional $5 million of the Company's outstanding common stock, effective immediately. The expanded repurchase program signals management's confidence in the company's financial position and commitment to returning capital to shareholders.

• · The stock repurchase program expansion was approved by the Board of Directors and becomes effective on June 1, 2026.
• · The company serves as the holding company for Embassy Bank For the Lehigh Valley.

01-06-2026

The Trade Desk announced the appointment of Nate Olmstead as Chief Financial Officer, effective July 9, 2026, succeeding interim CFO Tahnil Davis, who will return to her previous role as Chief Accounting Officer. Olmstead brings extensive financial leadership experience from Penguin Solutions, Logitech, and Hewlett Packard. The change is positioned to support the company's continued growth and profitability, with no negative or flat metrics reported in the filing.

• · Nate Olmstead's appointment as CFO is effective July 9, 2026.
• · Olmstead will report directly to CEO Jeff Green.
• · Tahnil Davis has been with The Trade Desk for 11 years and will continue as Chief Accounting Officer, reporting to Olmstead.
• · Olmstead previously served as SVP and CFO of Penguin Solutions and CFO of Logitech International S.A.
• · Olmstead spent 16 years in financial leadership roles at Hewlett Packard Company and Hewlett Packard Enterprise.

01-06-2026

Avis Budget Group issued $300M of 8.000% Senior Notes due 2031, adding to the existing $500M of the same series. Proceeds will be used to redeem a portion of its 5.750% Senior Notes due 2027 and pay fees. The notes are guaranteed on a senior unsecured basis by the company and certain subsidiaries.

• · The New Notes were issued under a Base Indenture dated November 22, 2023, supplemented by a First Supplemental Indenture dated May 29, 2026.
• · Interest on the New Notes accrues from May 15, 2026, with first payment on November 15, 2026.
• · The Issuers may redeem all or part of the Notes at any time prior to November 15, 2026 at a make-whole premium, and on or after that date at specified redemption prices.
• · Up to 40% of the aggregate principal amount may be redeemed with equity offering proceeds prior to November 15, 2026.
• · Upon a change of control, ABCR must offer to repurchase the Notes at 101% of principal plus accrued interest.
• · The Indenture includes covenants limiting dividends, liens, investments, asset sales, mergers, and subsidiary designations.

01-06-2026

Civista Bancshares, Inc. (CIVB) announced its participation at the Performance Trust Capital Connect Conference on June 2, 2026, where its executive leadership team will discuss banking trends, strategic growth initiatives, and the company's long-term outlook. The company furnished its First Quarter 2026 Investor Presentation as Exhibit 99.1. The filing is under Regulation FD and does not contain any financial results or period-over-period comparisons.

• · Civista Bank was founded in 1884 and operates 44 locations across Ohio, Southeastern Indiana, and Northern Kentucky.
• · Civista Bank offers commercial equipment leasing services nationwide through its Civista Leasing and Finance Division.
• · The company's common shares trade on the NASDAQ Capital Market under the symbol CIVB.

01-06-2026

ProPhase Labs, Inc. filed its 2025 10-K, reporting a net loss improvement to $14.7M from $53.3M in 2024, driven by a significant reduction in operating losses and gain from discontinued operations. Revenue declined 35.8% to $4.3M, but gross profit turned positive at $1.4M versus a prior loss. The company raised $6.9M in financing activities and reduced its cash position to $0.09M, while total assets fell slightly to $59.9M.

• · Adjusted EBITDA from continuing operations improved to -$6.9M in 2025 from -$17.9M in 2024.
• · Debt extinguishment gain of $0.8M and employee retention tax credit income of $2.3M boosted 2025 results.
• · Cash used in operating activities (continuing) was -$8.9M in 2025 vs -$11.8M in 2024.
• · The company recognized a $43.7M investment in unconsolidated affiliates and deconsolidated $16M in assets/liabilities.
• · Accounts payable to unconsolidated affiliates stood at $27.6M at year-end 2025, compared to zero in 2024.
• · Total current liabilities surged to $53.1M from $32.1M, driven by the affiliate payables and increased short-term debt.
• · Accumulated deficit widened to -$73.1M from -$58.4M.
• · Weighted average basic shares outstanding increased dramatically to 8.5 million from 2.0 million, reflecting significant dilution.

01-06-2026

Bank of Marin Bancorp held its Annual Meeting on May 27, 2026, where shareholders elected ten directors, approved executive compensation on an advisory basis, and ratified Baker Tilly US as independent auditor for 2026. All director nominees received strong support, with the lowest 'for' votes being 7,509,925 for Russell A. Colombo (67.1% of votes cast), while the highest was 10,985,406 for Joel Sklar, MD (98.2% of votes cast). The advisory vote on executive compensation passed with 10,370,963 for (92.7% of votes cast), though 479,866 abstained. The Board also approved committee compositions effective May 27, 2026.

• · Russell A. Colombo received the lowest 'for' votes among directors at 7,509,925, with 3,680,478 withheld (32.9% of votes cast).
• · The ratification of Baker Tilly US as auditor received 12,980,394 for, 80,959 against, and 61,336 abstentions, with no broker non-votes.
• · Broker non-votes totaled 1,932,287 for all director elections and the executive compensation vote, but zero for the auditor ratification.
• · The Compensation Committee is chaired by Joel Sklar, MD, and includes Nicolas C. Anderson, Charles D. Fite, Cigdem F. Gencer, and Kevin R. Kennedy.
• · The Audit Committee is chaired by Nicolas C. Anderson and includes Cigdem F. Gencer, James C. Hale, Brian M. Sobel, and Secil T. Watson.
• · The Nominating and Governance Committee is chaired by Secil T. Watson and includes Nicolas C. Anderson, Charles D. Fite, James C. Hale, and Joel Sklar, MD.

01-06-2026

Light & Wonder, Inc. filed definitive additional proxy materials (DEFA14A) on June 1, 2026, providing CDI holders with instructions for voting and attending the virtual Annual Meeting of Stockholders on June 11, 2026. CDI holders cannot vote or ask questions live during the meeting but must submit voting instructions by June 5, 2026, and may submit questions in advance via an online portal. The filing also notes that the company has over 6,500 employees and operates three business segments.

• · Record date for stockholders is April 13, 2026 PDT.
• · Voting deadline for CDI holders is 12:00 p.m. AEST on June 5, 2026 (7:00 p.m. PDT on June 4, 2026).
• · Questions must be submitted by 2:59 p.m. AEST on June 10, 2026.
• · Meeting webcast access begins at 8:45 a.m. AEST on June 11, 2026.
• · CDI holders can submit voting instructions online at www.investorvote.com.au, by post, or by fax.
• · CDI holders can attend as guests via the webcast link.